If a patient develops hives from Gantrisin, what allergy should be noted on their profile?
If a patient develops hives from Gantrisin, what allergy should be noted on their profile?
Share
Lost your password? Please enter your email address. You will receive a link and will create a new password via email.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
If a patient develops hives (urticaria) after taking Gantrisin, the allergy that should be noted on their profile is:
Sulfisoxazole allergy
Gantrisin is the brand name for the antibiotic sulfisoxazole. It belongs to the sulfonamide class of antibiotics.
Hives or urticaria is a type of allergic reaction that causes raised, itchy red bumps or welts on the skin. It is a common manifestation of an allergic response to sulfonamide antibiotics like sulfisoxazole.
When a patient experiences an allergic reaction like hives to a particular medication, it is crucial to document the specific drug allergen in their medical record and allergy profile. This alerts healthcare providers to avoid prescribing that drug or related compounds in the future to prevent recurrence of the reaction.
In this case, since the reaction occurred after taking Gantrisin (sulfisoxazole), the allergy that needs to be documented is a sulfisoxazole allergy or sulfonamide allergy. This will help prevent re-exposure to sulfisoxazole or other sulfa drugs, which could potentially trigger a more severe allergic reaction.
It’s important to note the specific allergen rather than just “antibiotic allergy” to allow for appropriate future antimicrobial selection if needed.
Allergy to sulfa drugs ( generic name is sulfisoxazole )